Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
168,155,271
-
Share change
-
+8,518,101
-
Total reported value
-
$15,553,010,289
-
Put/Call ratio
-
123%
-
Price per share
-
$92.52
-
Number of holders
-
417
-
Value change
-
+$820,607,801
-
Number of buys
-
236
-
Number of sells
-
149
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q3 2016
As of 30 Sep 2016,
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) was held by
417 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
168,155,271 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, JENNISON ASSOCIATES LLC, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and JPMORGAN CHASE & CO.
This page lists
417
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.